296 related articles for article (PubMed ID: 25537518)
1. Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.
Liu L; Kimball S; Liu H; Holowatyj A; Yang ZQ
Oncotarget; 2015 Feb; 6(4):2466-82. PubMed ID: 25537518
[TBL] [Abstract][Full Text] [Related]
2. Genetic alteration of histone lysine methyltransferases and their significance in renal cell carcinoma.
Yan L; Zhang Y; Ding B; Zhou H; Yao W; Xu H
PeerJ; 2019; 7():e6396. PubMed ID: 30755832
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
Michalak EM; Visvader JE
Mol Oncol; 2016 Dec; 10(10):1497-1515. PubMed ID: 27717710
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Zhang Y; Yan L; Yao W; Chen K; Xu H; Ye Z
Med Sci Monit; 2019 Jan; 25():193-239. PubMed ID: 30616239
[TBL] [Abstract][Full Text] [Related]
5. KMT2C and KMT2D aberrations in breast cancer.
Tinsley E; Bredin P; Toomey S; Hennessy BT; Furney SJ
Trends Cancer; 2024 Jun; 10(6):519-530. PubMed ID: 38453563
[TBL] [Abstract][Full Text] [Related]
6. A Computational Approach to Predict the Role of Genetic Alterations in Methyltransferase Histones Genes With Implications in Liver Cancer.
Aravena TI; Valdés E; Ayala N; D'Afonseca V
Cancer Inform; 2023; 22():11769351231161480. PubMed ID: 37008071
[TBL] [Abstract][Full Text] [Related]
7. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
8. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.
Yu H; Jiang Y; Liu L; Shan W; Chu X; Yang Z; Yang ZQ
Oncotarget; 2017 Feb; 8(8):13099-13115. PubMed ID: 28055972
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
Ding B; Yan L; Zhang Y; Wang Z; Zhang Y; Xia D; Ye Z; Xu H
FEBS Open Bio; 2019 Apr; 9(4):693-706. PubMed ID: 30984543
[TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of selected histone methylases and demethylases in prostate carcinoma.
Vieira FQ; Costa-Pinheiro P; Ramalho-Carvalho J; Pereira A; Menezes FD; Antunes L; Carneiro I; Oliveira J; Henrique R; Jerónimo C
Endocr Relat Cancer; 2014 Feb; 21(1):51-61. PubMed ID: 24200674
[TBL] [Abstract][Full Text] [Related]
11. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
Jiang Y; Liu L; Shan W; Yang ZQ
Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
[TBL] [Abstract][Full Text] [Related]
12. Transforming properties of 8p11-12 amplified genes in human breast cancer.
Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of selected histone modifier genes in human solid cancers.
Ozdağ H; Teschendorff AE; Ahmed AA; Hyland SJ; Blenkiron C; Bobrow L; Veerakumarasivam A; Burtt G; Subkhankulova T; Arends MJ; Collins VP; Bowtell D; Kouzarides T; Brenton JD; Caldas C
BMC Genomics; 2006 Apr; 7():90. PubMed ID: 16638127
[TBL] [Abstract][Full Text] [Related]
14. Expression of four histone lysine-methyltransferases in parotid gland tumors.
Aniello F; Colella G; Muscariello G; Lanza A; Ferrara D; Branno M; Minucci S
Anticancer Res; 2006; 26(3A):2063-7. PubMed ID: 16827145
[TBL] [Abstract][Full Text] [Related]
15. Histone methyltransferases in cancer.
Albert M; Helin K
Semin Cell Dev Biol; 2010 Apr; 21(2):209-20. PubMed ID: 19892027
[TBL] [Abstract][Full Text] [Related]
16. Histone Methyltransferases Useful in Gastric Cancer Research.
Reyes DA; Sarría VMS; Salazar-Viedma M; D'Afonseca V
Cancer Inform; 2021; 20():11769351211039862. PubMed ID: 34413625
[TBL] [Abstract][Full Text] [Related]
17. Somatic Cancer Mutations in the SUV420H1 Protein Lysine Methyltransferase Modulate Its Catalytic Activity.
Bröhm A; Elsawy H; Rathert P; Kudithipudi S; Schoch T; Schuhmacher MK; Weirich S; Jeltsch A
J Mol Biol; 2019 Aug; 431(17):3068-3080. PubMed ID: 31255706
[TBL] [Abstract][Full Text] [Related]
18. Chemical probes of histone lysine methyltransferases.
Kaniskan HÜ; Jin J
ACS Chem Biol; 2015 Jan; 10(1):40-50. PubMed ID: 25423077
[TBL] [Abstract][Full Text] [Related]
19. Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer.
Salz T; Deng C; Pampo C; Siemann D; Qiu Y; Brown K; Huang S
Mol Cancer Res; 2015 Mar; 13(3):461-9. PubMed ID: 25373480
[TBL] [Abstract][Full Text] [Related]
20. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
Kunizaki M; Hamamoto R; Silva FP; Yamaguchi K; Nagayasu T; Shibuya M; Nakamura Y; Furukawa Y
Cancer Res; 2007 Nov; 67(22):10759-65. PubMed ID: 18006819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
